Cited 0 time in
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tai, Mei-Chee | - |
| dc.contributor.author | Dennis, Joe | - |
| dc.contributor.author | Park, Sue K. | - |
| dc.contributor.author | Kim, Sung-Won | - |
| dc.contributor.author | Lee, Jong Won | - |
| dc.contributor.author | Hassan, Nur Tiara | - |
| dc.contributor.author | Kwong, Ava | - |
| dc.contributor.author | Hartman, Mikael | - |
| dc.contributor.author | Yoon, Sook-Yee | - |
| dc.contributor.author | Ngeow, Joanne | - |
| dc.contributor.author | Woo, Yin-Ling | - |
| dc.contributor.author | Park, Boyoung | - |
| dc.contributor.author | Wong, Zhi-Lei | - |
| dc.contributor.author | Leslie, Goska | - |
| dc.contributor.author | Bolla, Manjeet K. | - |
| dc.contributor.author | Barnes, Daniel R. | - |
| dc.contributor.author | Parsons, Michael T. | - |
| dc.contributor.author | Soucy, Penny | - |
| dc.contributor.author | Simard, Jacques | - |
| dc.contributor.author | Mohd Taib, Nur Aishah | - |
| dc.contributor.author | Yip, Cheng-Har | - |
| dc.contributor.author | Easton, Douglas F. | - |
| dc.contributor.author | Chenevix-Trench, Georgia | - |
| dc.contributor.author | Antoniou, Antonis C. | - |
| dc.contributor.author | Teo, Soo-Hwang | - |
| dc.contributor.author | Ho, Weang-Kee | - |
| dc.date.accessioned | 2025-11-17T00:30:25Z | - |
| dc.date.available | 2025-11-17T00:30:25Z | - |
| dc.date.issued | 2025-09 | - |
| dc.identifier.issn | 2374-4677 | - |
| dc.identifier.issn | 2374-4677 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/209173 | - |
| dc.description.abstract | Polygenic risk scores (PRS) have been shown to be predictive of breast cancer (BC) risk in European BRCA1 and BRCA2 pathogenic variant (PV) carriers, but their utility in Asian populations has not been evaluated. In this study, we evaluated the association of two breast cancer PRS developed for the East Asian general population and three versions of a PRS developed for the European general population in 604 BRCA1 (390 affected by breast cancer) and 785 BRCA2 (552 affected by breast cancer) PV female carriers of Asian ancestry. Only the Asian-based PRS, constructed using approximately 1 million single-nucleotide variations (SNVs), showed a significant association with breast cancer risk (Hazard Ratio per standard deviation (95% Confidence Interval) is 1.47 (1.10-1.95) for BRCA1 and 1.43 (1.04-1.95) for BRCA2). Incorporating this PRS into risk prediction models may improve cancer risk assessment among PV carriers of Asian ancestry. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Springer Nature | - |
| dc.title | Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1038/s41523-025-00820-0 | - |
| dc.identifier.scopusid | 2-s2.0-105017795187 | - |
| dc.identifier.wosid | 001584756100001 | - |
| dc.identifier.bibliographicCitation | npj Breast Cancer, v.11, no.1, pp 1 - 6 | - |
| dc.citation.title | npj Breast Cancer | - |
| dc.citation.volume | 11 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 6 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.identifier.url | https://www.nature.com/articles/s41523-025-00820-0 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
